Shire bids $30.6bn for Baxalta
Rare disease specialist Baxalta has advised shareholders to reject a second takeover offer from Shire, this time for $30.6bn.
Archives for August 6, 2015
Cellular Therapeutics bags immune cell production contract
Specialist manufacturer Cellular Therapeutics has been awarded a contract from the UK Cell Therapy Catapult to produce a new cell-based cancer therapy.